Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its OpenAlex record.

Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

ROBERT E. WALKER, Christine M. Bechtel, Ven Natarajan, Michael Baseler, Kristen M. Hege, Julia A. Metcalf, Randy A. Stevens, Allison Hazen, R. Michael Blaese, Clara C. Chen, Susan F. Leitman, Jolie Palensky, Janet Wittes, Richard T. Davey, Judith Falloon, Michael Alan Polis, Joseph A. Kovacs, David Broad, Bruce L. Levine, Margo R. Roberts, Henry Masur, Henry Clifford Lane · 2000 · PubMed

Abstract

To study human immunodeficiency virus (HIV)-specific cellular immunity in vivo, we transferred syngeneic lymphocytes after ex vivo expansion and transduction with a chimeric receptor gene (CD4/CD3-zeta) between identical twins discordant for HIV infection. Single and multiple infusions of 10(10) genetically modified CD8(+) T cells resulted in peak fractions in the circulation of approximately 10(4) to 10(5) modified cells/10(6) mononuclear cells at 24 to 48 hours, followed by 2- to 3-log declines by 8 weeks. In an effort to provide longer high-level persistence of the transferred cells and possibly enhance anti-HIV activity, we administered a second series of infusions in which both CD4(+ )and CD8(+) T cells were engineered to express the chimeric receptor and were costimulated ex vivo with beads coated with anti-CD3 and anti-CD28. Sustained fractions of approximately 10(3) to 10(4) modified cells/10(6) total CD4(+) or CD8(+) cells persisted for at least 1 year. Assessment of in vivo trafficking of the transferred cells by lymphoid tissue biopsies revealed the presence of modified cells in proportions equivalent to or below those in the circulation. The cell infusions were well tolerated and were not associated with substantive immunologic or virologic changes. Thus, adoptive transfer of genetically modified HIV-antigen-specific T cells was safe. Sustained survival in the circulation was achieved when modified CD4(+ )and CD8(+) T cells were infused together after ex vivo costimulation, indicating the important role played by antigen-specific CD4(+) T cells in providing "help" to cytotoxic effectors. (Blood. 2000;96:467-474)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1182/blood.v96.2.467

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 222

Metadata

Authors
WALKER, R. E., Bechtel, C. M., Natarajan, V., Baseler, M., Hege, K. M., Metcalf, J. A., Stevens, R. A., Hazen, A., Blaese, R. M., Chen, C. C., Leitman, S. F., Palensky, J., Wittes, J., Davey, R. T., Falloon, J., Polis, M. A., Kovacs, J. A., Broad, D., Levine, B. L., Roberts, M. R., Masur, H., & Lane, H. C.
Venue
PubMed
Publisher
National Institutes of Health
Published
2000-07-15
Volume
96
Issue
2
Pages
467-74
OpenAlex
W1905863650
Cited by
222
References
0
FWCI
2.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. https://app.cochat.ai/papers/10.1182/blood.v96.2.467
The paper
WALKER, R. E., Bechtel, C. M., Natarajan, V., Baseler, M., Hege, K. M., Metcalf, J. A., Stevens, R. A., Hazen, A., Blaese, R. M., Chen, C. C., Leitman, S. F., Palensky, J., Wittes, J., Davey, R. T., Falloon, J., Polis, M. A., Kovacs, J. A., Broad, D., Levine, B. L., . . . Lane, H. C. (2000). Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. PubMed. https://doi.org/10.1182/blood.v96.2.467

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.